FATE Historical PE Ratio image   This FATE PE ratio history page last updated 8/5/2022
FATE PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/3/2022
32.81-0.79-2.64NA
Q1 2022
5/4/2022
30.69-0.68-2.43NA
Q4 2021
2/28/2022
34.55-0.72-2.23NA
Q3 2021
11/4/2021
59.65-0.45-2.12NA
Q2 2021
8/4/2021
85.73-0.58-2.35NA
Q1 2021
5/5/2021
77.73-0.48-2.12NA
Q4 2020
2/24/2021
95.27-0.61-2.08NA
Q3 2020
11/5/2020
49.92-0.68-1.84NA
Q2 2020
8/5/2020
32.84-0.35-1.56NA
Q1 2020
5/11/2020
30.22-0.44-1.57NA
Q4 2019
3/2/2020
31.01-0.37-1.43NA
Q3 2019
11/5/2019
15.71-0.40-1.31NA
Q2 2019
8/6/2019
19.82-0.36-1.22NA
Q1 2019
5/7/2019
16.98-0.30-1.23NA
Q4 2018
3/5/2019
16.03-0.25-1.20NA
Q3 2018
11/1/2018
13.61-0.31-1.24NA
Q2 2018
8/6/2018
10.17-0.37-1.19NA
Q1 2018
5/10/2018
10.96-0.27-1.05NA
Q4 2017
3/5/2018
13.77-0.29-1.02NA
Q3 2017
11/1/2017
4.69-0.26-0.94NA
Q2 2017
8/14/2017
3.09-0.23-0.95NA
Q1 2017
5/15/2017
4.11-0.24-1.01NA
Q4 2016
3/16/2017
4.64-0.21-1.06NA
Q3 2016
11/7/2016
1.97-0.27-1.11NA
Q2 2016
8/8/2016
2.59-0.29-1.08NA
Q1 2016
5/9/2016
1.73-0.29-1.12NA
Q4 2015
3/3/2016
1.83-0.26-1.21NA
Q3 2015
11/3/2015
4.52-0.24-1.25NA
Q2 2015
8/5/2015
6.87-0.33-1.33NA
Q1 2015
5/7/2015
7.19-0.38-1.30NA
Q4 2014
3/12/2015
5.08-0.30-1.26NA
Q3 2014
11/11/2014
3.95-0.32-1.25NA
Q2 2014
8/12/2014
6.00-0.30-5.74NA
Q1 2014
5/13/2014
6.56-0.34NANA
Q4 2013
3/17/2014
10.43-0.29NANA
Q3 2013
11/13/2013
5.16-4.81NANA
FATE Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/3/2022
32.81-0.79-3.16NA
Q1 2022
5/4/2022
30.69-0.68-2.72NA
Q4 2021
2/28/2022
34.55-0.72-2.88NA
Q3 2021
11/4/2021
59.65-0.45-1.80NA
Q2 2021
8/4/2021
85.73-0.58-2.32NA
Q1 2021
5/5/2021
77.73-0.48-1.92NA
Q4 2020
2/24/2021
95.27-0.61-2.44NA
Q3 2020
11/5/2020
49.92-0.68-2.72NA
Q2 2020
8/5/2020
32.84-0.35-1.40NA
Q1 2020
5/11/2020
30.22-0.44-1.76NA
Q4 2019
3/2/2020
31.01-0.37-1.48NA
Q3 2019
11/5/2019
15.71-0.40-1.60NA
Q2 2019
8/6/2019
19.82-0.36-1.44NA
Q1 2019
5/7/2019
16.98-0.30-1.20NA
Q4 2018
3/5/2019
16.03-0.25-1.00NA
Q3 2018
11/1/2018
13.61-0.31-1.24NA
Q2 2018
8/6/2018
10.17-0.37-1.48NA
Q1 2018
5/10/2018
10.96-0.27-1.08NA
Q4 2017
3/5/2018
13.77-0.29-1.16NA
Q3 2017
11/1/2017
4.69-0.26-1.04NA
Q2 2017
8/14/2017
3.09-0.23-0.92NA
Q1 2017
5/15/2017
4.11-0.24-0.96NA
Q4 2016
3/16/2017
4.64-0.21-0.84NA
Q3 2016
11/7/2016
1.97-0.27-1.08NA
Q2 2016
8/8/2016
2.59-0.29-1.16NA
Q1 2016
5/9/2016
1.73-0.29-1.16NA
Q4 2015
3/3/2016
1.83-0.26-1.04NA
Q3 2015
11/3/2015
4.52-0.24-0.96NA
Q2 2015
8/5/2015
6.87-0.33-1.32NA
Q1 2015
5/7/2015
7.19-0.38-1.52NA
Q4 2014
3/12/2015
5.08-0.30-1.20NA
Q3 2014
11/11/2014
3.95-0.32-1.28NA
Q2 2014
8/12/2014
6.00-0.30-1.20NA
Q1 2014
5/13/2014
6.56-0.34-1.36NA
Q4 2013
3/17/2014
10.43-0.29-1.16NA
Q3 2013
11/13/2013
5.16-4.81-19.24NA
Quotes delayed 20 minutes

Email EnvelopeFree FATE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Fate Therapeutics (FATE) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

FBIO PE Ratio History
FBRX PE Ratio History
FDMT PE Ratio History
FEMY PE Ratio History
FGEN PE Ratio History
FHTX PE Ratio History
FIXX PE Ratio History
FLDM PE Ratio History
FLGT PE Ratio History
FLXN PE Ratio History
On this page we presented the FATE PE Ratio History information for Fate Therapeutics' stock. The average FATE PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average FATE PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this FATE PE ratio history result, against the recent PE: when this page was posted on 8/4/2022, the most recent closing price for FATE had been 32.55, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on FATE or any other given stock, valuation analysis for FATE can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Fate Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for FATE. Thanks for visiting, and the next time you need to research FATE PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: PXSC Historical Stock Prices, Top Ten Hedge Funds Holding FSLY, Funds Holding MPSX.

 

FATE PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.